Summary: A new study reports those with the highest genetic propensity to mental illness are twice as likely to be hospitalized for depression than those with the lowest propensity.
Source: Aarhus University.
In a new study, researchers from the Danish iPSYCH project demonstrate that people with the highest genetic propensity are over two and a half times as likely to be treated in a psychiatric hospital for depression compared to people with the lowest propensity. This knowledge could be utilised to strengthen preventative efforts for those who are at risk.
In Denmark, 15.5 per cent of woman and nine per cent of men receive treatment for depression at a psychiatric hospital at some stage of their lives. Depression is a common but very serious condition which is very costly for both the individual and society as a whole.
Researchers have now completed a study in which they followed 34,500 Danes for up to 20 years and measured their genetic risk for developing depression.
“The study showed that the risk of being treated for depression at a psychiatric hospital was more than two and a half times higher for people with a high polygenic risk score,” explains professor at iPSYCH and contributor to the study Esben Agerbo.
Polygenetic means that the disease is not connected to only one disease gene, but to many genes. Put another way, it means there are many genes that determine whether a person is predisposed to developing depression.
Easier to identify people
“We know that depression is partly determined by genetic factors, and today it’s possible to measure the genetic propensity directly – rather than having to rely on family history as a way of guessing at genetic disposition for developing depression,” explains Esben Agerbo.
The polygenetic score was not related to factors such as mild, moderate, severe or psychotic symptoms, treatment setting or age at the first hospital visit, which could mean that these aspects are determined more by environmental factors.
The results of the study have just been published in the scientific journal JAMA Psychiatry.
“Our hope is that by utilising genetic information in conjunction with known risk factors in the environment, we will be able to develop better methods to identify people who are at risk of developing depression,” says postdoc at iPSYCH, Katherine L. Musliner, who is behind the study.
However, the results also show that the relationship between genetics and mental illness is complex. There is no ‘ depression gene’ and even those with the highest genetic propensity will not necessarily develop depression.
“The ability to identify people with an increased risk of developing depression is useful, because it will make it possible for us to target preventative efforts towards the people who will benefit most from them,” says Katherine L. Musliner.
About mono- and polygenetic diseases?
Multiple genes and the way they interact may have significance for whether a person is predisposed to suffer from different diseases. A distinction is made between mono- and polygenetic diseases depending on whether one or multiple genes play a role in disease risk. For the majority of diseases, environmental factors also have a bearing on whether the disease develops. For example, a person may live their whole life with a genetic disposition for depression without ever experiencing a depressive episode. But they may experience depression following events such as shocks or a death in the family etc.
About this neuroscience research article
The study is a register-based study.
The partners involved in the study are: Nis Suppli, John McGrath, Jonas Bybjerg-Grauholm, Marie Bækvad-Hansen, Ole Andreassen, Carsten B Pedersen, Marianne G Pedersen, Bipolar Work Group of the PGC and iPSYCH PIs: Ole Mors, Thomas Werge, Merete Nordentoft, David Hougaard, Anders Børglum and Preben Bo Mortensen.
Funding: The study is financed by the Lundbeck Foundation.
Source: Katherine L Musiner – Aarhus University Publisher: Organized by NeuroscienceNews.com. Image Source: NeuroscienceNews.com image is in the public domain. Original Research:Abstract for “Association of Polygenic Liabilities for Major Depression, Bipolar Disorder, and Schizophrenia With Risk for Depression in the Danish Population” by Katherine L. Musliner, PhD; Preben B. Mortensen, DrMedSc; John J. McGrath, PhD; Nis P. Suppli, MD, PhD; David M. Hougaard, DrMedSc; Jonas Bybjerg-Grauholm, MSE; Marie Bækvad-Hansen, PhD; Ole Andreassen, MD; Carsten B. Pedersen, PhD; Marianne G. Pedersen, MSc; Ole Mors, MD; Merete Nordentoft, PhD; Anders D. Børglum, MD, PhD; Thomas Werge, PhD; Esben Agerbo, PhD; for the Bipolar Disorder Working Group of the Psychiatric Genomics in JAMA Psychiatry. Published January 30 2019. doi:10.1001/jamapsychiatry.2018.4166
Cite This NeuroscienceNews.com Article
[cbtabs][cbtab title=”MLA”]Aarhus University”New Knowledge Could Help Predict and Prevent Depression.” NeuroscienceNews. NeuroscienceNews, 31 February 2019. <https://neurosciencenews.com/depression-genetics-10673/>.[/cbtab][cbtab title=”APA”]Aarhus University(2019, February 31). New Knowledge Could Help Predict and Prevent Depression. NeuroscienceNews. Retrieved February 31, 2019 from https://neurosciencenews.com/depression-genetics-10673/[/cbtab][cbtab title=”Chicago”]Aarhus University”New Knowledge Could Help Predict and Prevent Depression.” https://neurosciencenews.com/depression-genetics-10673/ (accessed February 31, 2019).[/cbtab][/cbtabs]
Association of Polygenic Liabilities for Major Depression, Bipolar Disorder, and Schizophrenia With Risk for Depression in the Danish Population
Importance Although the usefulness of polygenic risk scores as a measure of genetic liability for major depression (MD) has been established, their association with depression in the general population remains relatively unexplored.
Objective To evaluate whether polygenic risk scores for MD, bipolar disorder (BD), and schizophrenia (SZ) are associated with depression in the general population and explore whether these polygenic liabilities are associated with heterogeneity in terms of age at onset and severity at the initial depression diagnosis.
Design, Setting, and Participants Participants were drawn from the Danish iPSYCH2012 case-cohort study, a representative sample drawn from the population of Denmark born between May 1, 1981, and December 31, 2005. The hazard of depression was estimated using Cox regressions modified to accommodate the case-cohort design. Case-only analyses were conducted using linear and multinomial regressions. The data analysis was conducted from February 2017 to June 2018.
Exposures Polygenic risk scores for MD, BD, and SZ trained using the most recent genome-wide association study results from the Psychiatric Genomics Consortium.
Main Outcomes and Measures The main outcome was first depressive episode (International Statistical Classification of Diseases and Related Health Problems, Tenth Revision [ICD-10] code F32) treated in hospital-based psychiatric care. Severity at the initial diagnosis was measured using the ICD-10 code severity specifications (mild, moderate, severe without psychosis, and severe with psychosis) and treatment setting (inpatient, outpatient, and emergency).
Results Of 34 573 participants aged 10 to 31 years at censoring, 68% of those with depression were female compared with 48.9% of participants without depression. Each SD increase in polygenic liability for MD, BD, and SZ was associated with 30% (hazard ratio [HR], 1.30; 95% CI, 1.27-1.33), 5% (HR, 1.05; 95% CI, 1.02-1.07), and 12% (HR, 1.12; 95% CI, 1.09-1.15) increases in the hazard of depression, respectively. Among cases, a higher polygenic liability for BD was associated with earlier depression onset (β = −.07; SE = .02; P = .002).
Conclusions and Relevance Polygenic liability for MD is associated with first depression in the general population, which supports the idea that these scores tap into an underlying liability for developing the disorder. The fact that polygenic risk for BD and polygenic risk for SZ also were associated with depression is consistent with prior evidence that these disorders share some common genetic overlap. Variations in polygenic liability may contribute slightly to heterogeneity in clinical presentation, but these associations appear minimal.